title: Antiviral activity of transiently expressed IFN-kappa is cell-associated.
abstract: Most type I interferons (IFNs) are expressed by the majority of cell types in response to viral infection. In contrast, IFN-kappa has been reported to have a cellular distribution limited to keratinocytes and certain lymphoid cell populations. Recombinant expressed IFN-kappa has been shown previously to possess weak antiviral activity when directly compared with IFN-beta. In order to expand on the antiviral potential of IFN-kappa, we transiently transfected human cell lines to circumvent the need to purify recombinant proteins and to avoid the possible loss of biologic activity by the purification process. We evaluated the transcriptional signaling and antiviral activity of IFN-kappa in parallel with IFN-alpha2b with mammalian expression vectors to express each protein transiently. Both IFN-kappa and IFN-alpha2b exhibited comparable transcriptional and antiviral activities. However, in contrast to IFN-alpha2b transcriptional signaling and antiviral activity, IFN-kappa activity was not detectable in conditioned cell culture medium. Subsequent experiments revealed there was a direct relationship between IFN-kappa-expressing cells and antiviral activity. These results were confirmed in immunocytochemical studies. Furthermore, IFN-kappa exhibited cell-associated antiviral activity against a hepatitis C virus (HCV) replicon cell line. This novel IFN signaling strategy may represent an important distinct and divergent mechanism for limiting viral infections.
authors.affiliation: Department of Antiviral Therapy, Schering-Plough Research Institute, Kenilworth, NJ 07033, USA. peter.buontempo@spcorp.com
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Buontempo
authors.forename: Ronald G
authors.initials: RG
authors.lastname: Jubin
authors.forename: Catherine A
authors.initials: CA
authors.lastname: Buontempo
authors.forename: Nicole E
authors.initials: NE
authors.lastname: Wagner
authors.forename: Gregory R
authors.initials: GR
authors.lastname: Reyes
authors.forename: Bahige M
authors.initials: BM
authors.lastname: Baroudy
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000276:immunology*; D002645:Chickens; D017077:Culture Media, Conditioned; D006367:HeLa Cells; D006801:Humans; D007370:Interferon Type I / Q000235:genetics / Q000276:immunology*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000235:genetics / Q000276:immunology; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology; D015398:Signal Transduction / Q000502:physiology; D014158:Transcription, Genetic; D014162:Transfection
chemical_list: D000998:Antiviral Agents; D017077:Culture Media, Conditioned; D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; C439669:interferon kappa